Skip to main content
. 2019 Jan 25;71(1):15–24. doi: 10.1016/j.ihj.2019.01.003

Fig. 2.

Fig. 2

Forest plot of ticagrelor versus clopidogrel for primary efficacy (A) and safety (B) endpoints. MACCEs: major adverse cardiac and cerebrovascular events; CI, confidence interval.